AbbVie stock was one of the top gainers in the S&P 500 Friday morning as the biotech firm's fourth-quarter revenue exceeded forecasts on higher sales of its Skyrizi and Rinvoq drugs to treat ...

Shares of the company began plunging in November, but its overall strength should set the stock up for some serious potential ...

Xylem (XYL) delivered earnings and revenue surprises of 5.36% and 3.37%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

Water analytics and treatment company Veralto (NYSE: VLTO) met Wall Street’s revenue expectations in Q4 CY2024, with sales up 4.4% year on year to $1.35 billion. Its non-GAAP profit of $0.95 per share ...

Q4 2024 Earnings Conference Call February 4, 2025 10:30 AM ETCompany ParticipantsFrancesca DeMartino - Senior Vice President, ...

Q1 2025 Earnings Call Transcript February 4, 2025 Fair Isaac Corporation misses on earnings expectations. Reported EPS is $5.79 EPS, expectations were $6.09. Operator: Good day and thank you for ...

Novo Nordisk today announced 2024 earnings, reporting a 26% increase in annual sales to ~$40.56bn. Read why I upgrade NVO ...

A.O. Smith Corporation reported its fourth-quarter 2024 earnings, revealing an earnings per share (EPS) of $0.85, which fell short of analysts' expectations of $0.90. The company's revenue also missed ...

The study may suggest that other researchers should be less optimistic about the prospects for treating a range of other ...

Recurve Capital, an investment management company, released its Q4 2024 investor letter. A copy of the letter can be downloaded here.

Hives, also known as urticaria, are raised, itchy welts on your skin that occur due to an allergen. The reaction is uncomfortable, but it’s often not serious.

Rob McElhenney teased that the Abbott Elementary/It's Always Sunny in Philadelphia Season 17 crossover may "surprise quite a few people." ...